Endo (NDOI) Preferred Dividends : $0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Endo Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Endo's preferred dividends for the three months ended in Dec. 2024 was $0 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Dec. 2024 was $0 Mil.

Endo Preferred Dividends Historical Data

The historical data trend for Endo's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Preferred Dividends Chart

Endo Annual Data

Trend

Dec22

Dec23

Dec24

Preferred Dividends

Endo Quarterly Data
	Jun23	Sep23	Dec23	Apr24	Sep24	Dec24
Preferred Dividends	Get a 7-Day Free Trial			-	-	-	-	-

Endo Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Endo (OTCPK:NDOI) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

Endo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Great Valley Parkway, Malvern, PA, USA, 19355

Website

https://www.endo.com

Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.